Mapping and size estimation of people who inject drugs: an innovative approach for targeted harm reduction program in Iran

References

• Amin-Esmaeili, M., Rahimi-Movaghar, A., Sharifi, V., Hajebi, A., Radgoodarzi, R., Mojtabai, R., Hefazi, M., & Motevalian, A. (2016). Epidemiology of illicit drug use disorders in Iran: Prevalence, correlates, comorbidity and service utilization results from the Iranian Mental Health Survey. Addiction, 111(10), 1836–1847. https://doi.org/10.1111/add.13453
   PubMed Web of Science ®Google Scholar
• Bouscaillou, J., Evanno, J., Prouté, M., Inwoley, A., Kabran, M., N’Guessan, T., Djé-Bi, S., Sidibé, S., Thiam-Niangoin, M., N’Guessan, B. R., Blanchetière, P., & Luhmann, N. (2016). Prevalence and risk factors associated with HIV and tuberculosis in people who use drugs in Abidjan, Ivory Coast. International Journal of Drug Policy, 30(1), 116–1231. https://doi.org/10.1016/j.drugpo.2016.02.010
   PubMed Web of Science ®Google Scholar
• Coffin, L. S., Newberry, A., Hagan, H., Cleland, C. M., Des Jarlais, D. C., & Perlman, D. C. (2010). Syphilis in drug users in low and middle income countries. International Journal of Drug Policy, 21(1), 20–27. https://doi.org/10.1016/j.drugpo.2009.02.008
   PubMed Web of Science ®Google Scholar
• Degenhardt, L., Whiteford, H. A., Ferrari, A. J., Baxter, A. J., Charlson, F. J., Hall, W. D., Freedman, G., Burstein, R., Johns, N., Engell, R. E., Flaxman, A., Murray, C. J., & Vos, T. (2013). Global burden of disease attributable to illicit drug use and dependence: Findings from the global burden of disease study 2010. The Lancet, 382(9904), 1564–1574. https://doi.org/10.1016/S0140-6736(13)61530-5
   PubMed Web of Science ®Google Scholar
• Emmanuel, F., Blanchard, J., Zaheer, H. A., Reza, T., & Holte-Mckenzie, M. (2010). The HIV/AIDS surveillance project mapping approach: An innovative approach for mapping and size estimation for groups at a higher risk of HIV in Pakistan. AIDS, 24(2), 77–84. https://doi.org/10.1097/01.aids.0000386737.25296.c4
   PubMedGoogle Scholar
• Khalili, M., Rahimi-Movaghar, A., Shadloo, B., Mojtabai, R., Mann, K., & Amin-Esmaeili, M. (2018). Global scientific production on illicit drug addiction: A two-decade analysis. European Addiction Research, 24(2), 60–70. https://doi.org/10.1159/000487590
   PubMed Web of Science ®Google Scholar
• Khodadost, M., Yavari, P., Babaei, M., Mosavi-Jarrahi, A., Sarvi, F., Mansori, K., & Khodadost, B. (2015). Estimating the completeness of gastric cancer registration in Ardabil/Iran by a capture-recapture method using population-based cancer registry data. Asian Pacific Journal of Cancer Prevention, 16(5), 1981–1986. https://doi.org/10.7314/APJCP.2015.16.5.1981
   PubMedGoogle Scholar
• Ndayongeje, J., Msami, A., Laurent, Y. I., Mwankemwa, S., Makumbuli, M., Ngonyani, A. M., Tiberio, J., Welty, S., Said, C., Morris, M. D., & McFarland, W. (2018). Illicit drug users in the Tanzanian hinterland: Population size estimation through key informant-driven hot spot mapping. AIDS and Behavior, 22(S1), 4–9. https://doi.org/10.1007/s10461-018-2057-x
   PubMedGoogle Scholar
• Nelson, P. K., Mathers, B. M., Cowie, B., Hagan, H., Des Jarlais, D., Horyniak, D., & Degenhardt, L. (2011). Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: Results of systematic reviews. The Lancet, 378(9791), 571–583. https://doi.org/10.1016/S0140-6736(11)61097-0
   PubMed Web of Science ®Google Scholar
• Nikfarjam, A., Shokoohi, M., Shahesmaeili, A., Haghdoost, A. A., Baneshi, M. R., Haji-Maghsoudi, S., Rastegari, A., Nasehi, A. A., Memaryan, N., & Tarjoman, T. (2016). National population size estimation of illicit drug users through the network scale-up method in 2013 in Iran. International Journal of Drug Policy, 31(1), 147–152. https://doi.org/10.1016/j.drugpo.2016.01.013
   PubMed Web of Science ®Google Scholar
• Noroozi, A., Malekinejad, M., & Rahimi-Movaghar, A. (2018). Factors influencing transition to shisheh (Methamphetamine) among young people who use drugs in Tehran: A qualitative study. Journal of Psychoactive Drugs, 50(3), 214–223. https://doi.org/10.1080/02791072.2018.1425808
   PubMed Web of Science ®Google Scholar
• Peacock, A., Leung, J., Larney, S., Colledge, S., Hickman, M., Rehm, J., Giovino, G. A., West, R., Hall, W., Griffiths, P., Ali, R., Gowing, L., Marsden, J., Ferrari, A. J., Grebely, J., Farrell, M., & Degenhardt, L. (2018). Global statistics on alcohol, tobacco and illicit drug use: 2017 status report. Addiction, 113(10), 1905–1926. https://doi.org/10.1111/add.14234
   PubMed Web of Science ®Google Scholar
• Riley, A. L., Hempel, B. J., & Clasen, M. M. (2018). Sex as a biological variable: Drug use and abuse. Physiology & Behavior, 187(1), 79–96. https://doi.org/10.1016/j.physbeh.2017.10.005
   PubMed Web of Science ®Google Scholar
• Scheibe, A., Shelly, S., Lambert, A., Schneider, A., Basson, R., Medeiros, N., Padayachee, K., Savva, H., & Hausler, H. (2017). Using a programmatic mapping approach to plan for HIV prevention and harm reduction interventions for people who inject drugs in three South African cities. Harm Reduction Journal, 14(1),1–12. https://doi.org/10.1186/s12954-017-0164-z
   Google Scholar
• Scheibe, A., Young, K., Moses, L., Basson, R. L., Versfeld, A., Spearman, C. W., Sonderup, M. W., Prabdial-Sing, N., Manamela, J., Puren, A. J., Rebe, K., & Hausler, H. (2019). Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: findings from a three-city cross-sectional survey. Harm Reduction Journal, 16(1),1–11. https://doi.org/10.1186/s12954-019-0298-2
   Google Scholar
• Shadloo, B., Amin-Esmaeili, M., Haft-Baradaran, M., Noroozi, A., Ghorban-Jahromi, R., & Rahimi-Movaghar, A. (2017). Use of amphetamine-type stimulants in the Islamic Republic of Iran, 2004-2015: A review. Eastern Mediterranean Health Journal, 23(3), 245–256. https://doi.org/10.26719/2017.23.3.245
   PubMed Web of Science ®Google Scholar
• Sharifi, H., Karamouzian, M., Baneshi, M. R., Shokoohi, M., Haghdoost, A., McFarland, W., Mirzazadeh, A., & Nishiura, H. (2017). Population size estimation of female sex workers in Iran: Synthesis of methods and results. PLoS One, 12(8), e0182755. https://doi.org/10.1371/journal.pone.0182755
   PubMed Web of Science ®Google Scholar
• World drug report 2019. United Nations Office on Drugs and Crime. Retrieved 2022/January/2 from https://wdr.unodc.org/wdr2019/prelaunch/WDR19_Booklet_1_EXECUTIVE_SUMMARY.pdf
   Google Scholar
• Zamani, S., Ichikawa, S., Nassirimanesh, B., Vazirian, M., Ichikawa, K., Gouya, M. M., Afshar, P., Ono-Kihara, M., Ravari, S. M., & Kihara, M. (2007). Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran. International Journal of Drug Policy, 18(5), 359–363. https://doi.org/10.1016/j.drugpo.2007.02.007
   PubMed Web of Science ®Google Scholar